239 related articles for article (PubMed ID: 12646453)
1. Imaging in oncology from the University of Texas M. D. Anderson Cancer Center. Imaging in the diagnosis, staging, and follow-up of cancer of the urinary bladder.
Kundra V; Silverman PM
AJR Am J Roentgenol; 2003 Apr; 180(4):1045-54. PubMed ID: 12646453
[No Abstract] [Full Text] [Related]
2. Diagnosis and staging of bladder cancer.
Cummings KB; Barone JG; Ward WS
Urol Clin North Am; 1992 Aug; 19(3):455-65. PubMed ID: 1636230
[TBL] [Abstract][Full Text] [Related]
3. [Guidelines for diagnosis of bladder cancer. German Society of Urology].
Urologe A; 1998 Jul; 37(4):441-57. PubMed ID: 9738301
[No Abstract] [Full Text] [Related]
4. Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients.
Kamat AM; Dinney CP; Gee JR; Grossman HB; Siefker-Radtke AO; Tamboli P; Detry MA; Robinson TL; Pisters LL
Cancer; 2007 Jul; 110(1):62-7. PubMed ID: 17542024
[TBL] [Abstract][Full Text] [Related]
5. [Your patient with carcinoma of the urinary bladder. Options for organ preservation].
Zaak D
MMW Fortschr Med; 2003 Jan; 145(5):28-32. PubMed ID: 12619205
[TBL] [Abstract][Full Text] [Related]
6. Cytologic diagnosis of occult and "in-situ" carcinoma of the urinary system.
Allegra SR; Fanning JP; Streker JF; Corvese NM
Acta Cytol; 1966; 10(5):340-9. PubMed ID: 5230228
[No Abstract] [Full Text] [Related]
7. Pretreatment staging of invasive transitional cell carcinoma of the bladder. American College of Radiology. ACR Appropriateness Criteria.
Bigongiari LR; Amis ES; Bluth EI; Bush WH; Choyke PL; Fritzsche P; Holder L; Newhouse JH; Sandler CM; Segal AJ; Resnick MI; Rutsky EA
Radiology; 2000 Jun; 215 Suppl():697-702. PubMed ID: 11037487
[No Abstract] [Full Text] [Related]
8. Follow-up imaging of bladder carcinoma. American College of Radiology. ACR Appropriateness Criteria.
Segal AJ; Amis ES; Bigongiari LR; Bluth EI; Bush WH; Choyke PL; Fritzsche PJ; Holder LE; Newhouse JH; Sandler CM; Resnick MI; Rutsky EA
Radiology; 2000 Jun; 215 Suppl():765-72. PubMed ID: 11037498
[No Abstract] [Full Text] [Related]
9. Classification of patients with bladder cancer: clinical versus pathologic staging.
Cummings KB
Prog Clin Biol Res; 1984; 162A():33-53. PubMed ID: 6483916
[No Abstract] [Full Text] [Related]
10. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
[TBL] [Abstract][Full Text] [Related]
11. [Bladder cancer as an incidental finding].
Mack D; Jakse G
Wien Klin Wochenschr; 1986 Mar; 98(6):175-8. PubMed ID: 3518247
[TBL] [Abstract][Full Text] [Related]
12. Pitfalls of clinical versus microscpic staging of cancer of the bladder in relationship to potential curability.
Baker R
Am Surg; 1970 May; 36(5):269-75. PubMed ID: 5439001
[No Abstract] [Full Text] [Related]
13. [The clinicopathological study of bladder tumor. 1. The study and attempt to clarify the growing mode of tumor quantitatively evaluated by mapping histology].
Hori N; Kinoshita N; Sugimura Y; Tajima K; Tochigi H; Kawamura J; Shiraishi T
Nihon Hinyokika Gakkai Zasshi; 1987 Nov; 78(11):2004-10. PubMed ID: 3450937
[No Abstract] [Full Text] [Related]
14. Outcome and patterns of recurrence of nonbilharzial pure squamous cell carcinoma of the bladder: a contemporary review of The University of Texas M D Anderson Cancer Center experience.
Kassouf W; Spiess PE; Siefker-Radtke A; Swanson D; Grossman HB; Kamat AM; Munsell MF; Guo CC; Czerniak BA; Dinney CP
Cancer; 2007 Aug; 110(4):764-9. PubMed ID: 17614317
[TBL] [Abstract][Full Text] [Related]
15. Carcinoma in a bladder diverticulum: presentation and treatment outcome.
Golijanin D; Yossepowitch O; Beck SD; Sogani P; Dalbagni G
J Urol; 2003 Nov; 170(5):1761-4. PubMed ID: 14532771
[TBL] [Abstract][Full Text] [Related]
16. [Morphology of bladder cancer with reference to cystectomy specimen].
Presse S; Savvas V; Kuntz RM
Pathologe; 1993 Sep; 14(5):253-9. PubMed ID: 8415434
[No Abstract] [Full Text] [Related]
17. [Determining the depth of infiltration in urinary bladder carcinoma with contrast medium enhanced dynamic magnetic resonance tomography. With reference to postoperative findings and inflammation].
Venz S; Ilg J; Ebert T; Hierholzer J; Friedrichs R; Hosten N; Felix R
Urologe A; 1996 Jul; 35(4):297-304. PubMed ID: 8928358
[TBL] [Abstract][Full Text] [Related]
18. [Diagnosis and substaging of pT1 bladder cancer].
Cheng L; Huang WB; Zheng SQ; Zheng J
Zhonghua Bing Li Xue Za Zhi; 2007 Sep; 36(9):636-9. PubMed ID: 18070458
[No Abstract] [Full Text] [Related]
19. The clinical value of CYFRA21-1 in bladder cancer patients: Egyptian experience.
el-Ahmady O; Halim AB; el-Din AG
Anticancer Res; 1999; 19(4A):2603-8. PubMed ID: 10470202
[TBL] [Abstract][Full Text] [Related]
20. [Invasiveness and metastases of bladder cancer].
Samsonov VA
Vopr Onkol; 1985; 31(6):64-8. PubMed ID: 3161241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
